Our gastric (stomach) cancer nomogram is a tool designed to predict the likelihood of surviving gastric cancer for five years and nine years after surgical treatment for the disease. This nomogram is appropriate for patients who have had a complete resection (surgical removal of all cancerous tissue) as their only treatment for gastric cancer. It may not be appropriate for patients who have received chemotherapy or radiation therapy before or after a complete resection for gastric cancer.
Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of gastric (stomach) cancer procedures. This tool has been evaluated and externally validated by two independent, high-volume gastric cancer centers (see Supporting Publications). All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
To gather the information required to use this nomogram, use our worksheet.